Header Logo

Connection

David Moore to Aged

Back to Details
This is a "connection" page, showing publications David Moore has written about Aged.
David Moore
Connection Strength
2,275
Aged
  1. A Cross-Sectional Study to Evaluate the Effects of Age and Duration of HIV Infection on Anxiety and Depression in Cisgender Men. AIDS Behav. 2022 Jan; 26(1):196-203.
    View in: PubMed
    Score: 0,132
  2. The utility of olfactory function in distinguishing early-stage Alzheimer's disease from HIV-associated neurocognitive disorders. AIDS. 2021 03 01; 35(3):429-437.
    View in: PubMed
    Score: 0,129
  3. Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study. Arch Clin Neuropsychol. 2021 Feb 12; 36(2):151-164.
    View in: PubMed
    Score: 0,129
  4. Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV. J Neurovirol. 2021 02; 27(1):160-167.
    View in: PubMed
    Score: 0,128
  5. Felt Age Discrepancy Differs by HIV Serostatus: A Secondary Analysis. J Assoc Nurses AIDS Care. 2020 Sep-Oct; 31(5):587-597.
    View in: PubMed
    Score: 0,125
  6. Brief Report: Frailty and HIV Disease Severity Synergistically Increase Risk of HIV-Associated Neurocognitive Disorders. J Acquir Immune Defic Syndr. 2020 08 15; 84(5):522-526.
    View in: PubMed
    Score: 0,124
  7. Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and Aging. AIDS Res Hum Retroviruses. 2019 Nov/Dec; 35(11-12):985-998.
    View in: PubMed
    Score: 0,116
  8. Health need assessment in an indigenous high-altitude population living on an island in Lake Titicaca, Perú. Int J Equity Health. 2019 06 18; 18(1):94.
    View in: PubMed
    Score: 0,115
  9. The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease. J Neurovirol. 2019 10; 25(5):661-672.
    View in: PubMed
    Score: 0,111
  10. At-Risk Alcohol Use is Associated with Antiretroviral Treatment Nonadherence Among Adults Living with HIV/AIDS. Alcohol Clin Exp Res. 2017 Aug; 41(8):1518-1525.
    View in: PubMed
    Score: 0,100
  11. Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults. J Acquir Immune Defic Syndr. 2017 Mar 01; 74(3):243-249.
    View in: PubMed
    Score: 0,098
  12. Antiretroviral therapy reduces neurodegeneration in HIV infection. AIDS. 2015 Jan 28; 29(3):323-30.
    View in: PubMed
    Score: 0,085
  13. HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence. AIDS Behav. 2012 Nov; 16(8):2257-66.
    View in: PubMed
    Score: 0,072
  14. Neopterin Relates to Lifetime Depression in Older Adults With HIV on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2022 04 01; 89(4):454-461.
    View in: PubMed
    Score: 0,035
  15. Fatigue is associated with worse cognitive and everyday functioning in older persons with HIV. AIDS. 2022 May 01; 36(6):763-772.
    View in: PubMed
    Score: 0,034
  16. Predictors of Transition to Frailty in Middle-Aged and Older People With HIV: A Prospective Cohort Study. J Acquir Immune Defic Syndr. 2021 12 15; 88(5):518-527.
    View in: PubMed
    Score: 0,034
  17. Multimorbidity networks associated with frailty among middle-aged and older people with HIV. AIDS. 2021 12 01; 35(15):2451-2461.
    View in: PubMed
    Score: 0,034
  18. Low CD4+ cell count nadir exacerbates the impacts of APOE e4 on functional connectivity and memory in adults with HIV. AIDS. 2021 04 01; 35(5):727-736.
    View in: PubMed
    Score: 0,032
  19. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment. Ophthalmology. 2021 08; 128(8):1209-1221.
    View in: PubMed
    Score: 0,032
  20. Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances. J Neurovirol. 2020 12; 26(6):888-898.
    View in: PubMed
    Score: 0,031
  21. Frailty and Neurocognitive Impairment: Impacts on Quality of Life in HIV. J Assoc Nurses AIDS Care. 2020 May-Jun; 31(3):290-300.
    View in: PubMed
    Score: 0,030
  22. Risk of developing cerebral ß-amyloid plaques with posttranslational modification among HIV-infected adults. AIDS. 2019 11 15; 33(14):2157-2166.
    View in: PubMed
    Score: 0,029
  23. Metabolic Syndrome and Neurocognitive Deficits in HIV Infection. J Acquir Immune Defic Syndr. 2019 05 01; 81(1):95-101.
    View in: PubMed
    Score: 0,028
  24. Depression and aging with HIV: Associations with health-related quality of life and positive psychological factors. J Affect Disord. 2019 05 15; 251:1-7.
    View in: PubMed
    Score: 0,028
  25. Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS. 2018 09 10; 32(14):2005-2015.
    View in: PubMed
    Score: 0,027
  26. Impact of time perspectives on texting intervention to reduce HIV/STI transmission among female sex workers in Tijuana and Ciudad Juarez, Mexico. J Behav Med. 2019 02; 42(1):111-127.
    View in: PubMed
    Score: 0,027
  27. Neurocognitive functioning predicts frailty index in HIV. Neurology. 2018 07 10; 91(2):e162-e170.
    View in: PubMed
    Score: 0,027
  28. Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection. AIDS. 2017 04 24; 31(7):973-979.
    View in: PubMed
    Score: 0,025
  29. Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012. BMC Infect Dis. 2017 02 27; 17(1):174.
    View in: PubMed
    Score: 0,024
  30. Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2017 Feb 01; 74(2):134-141.
    View in: PubMed
    Score: 0,024
  31. Feasibility and Acceptability of Ecological Momentary Assessment of Daily Functioning Among Older Adults with HIV. Am J Geriatr Psychiatry. 2017 Aug; 25(8):829-840.
    View in: PubMed
    Score: 0,024
  32. Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy at First Visit after HIV Diagnosis. Sci Rep. 2016 09 06; 6:32947.
    View in: PubMed
    Score: 0,024
  33. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013. Glob Heart. 2017 12; 12(4):315-322.e3.
    View in: PubMed
    Score: 0,023
  34. Good quality locally procured drugs can be as effective as internationally quality assured drugs in treating multi-drug resistant tuberculosis. PLoS One. 2015; 10(4):e0126099.
    View in: PubMed
    Score: 0,022
  35. UPSA-M: Feasibility and initial validity of a mobile application of the UCSD Performance-Based Skills Assessment. Schizophr Res. 2015 May; 164(1-3):187-92.
    View in: PubMed
    Score: 0,021
  36. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016 Apr; 23(6):636-48.
    View in: PubMed
    Score: 0,021
  37. HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS. 2014 Jun 01; 28(9):1297-306.
    View in: PubMed
    Score: 0,020
  38. Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients. Clin Infect Dis. 2014 Jul 15; 59(2):287-97.
    View in: PubMed
    Score: 0,020
  39. Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort. Int J Epidemiol. 2015 Feb; 44(1):58-67.
    View in: PubMed
    Score: 0,020
  40. The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment. J Acquir Immune Defic Syndr. 2014 Feb 01; 65(2):190-7.
    View in: PubMed
    Score: 0,020
  41. Allele-dose association of the C5orf30 rs26232 variant with joint damage in rheumatoid arthritis. Arthritis Rheum. 2013 Oct; 65(10):2555-61.
    View in: PubMed
    Score: 0,019
  42. Cerebral ß-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE e4 carriers. AIDS. 2012 Nov 28; 26(18):2327-35.
    View in: PubMed
    Score: 0,018
  43. Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr. 2011 Aug 15; 57(5):371-9.
    View in: PubMed
    Score: 0,017
  44. Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis. Rheumatology (Oxford). 2010 Nov; 49(11):2140-6.
    View in: PubMed
    Score: 0,015
  45. Two-year follow-up of sexual behavior among HIV-uninfected household members of adults taking antiretroviral therapy in Uganda: no evidence of disinhibition. AIDS Behav. 2010 Aug; 14(4):816-23.
    View in: PubMed
    Score: 0,014
  46. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS. 2005 Mar 04; 19(4):407-11.
    View in: PubMed
    Score: 0,011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.